Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
$1.35B
▼ -495.3% YoY
Op. Margin
–
ROIC
-4823.52%
▼ -385.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$120M
▼ -43.8% YoY
Op. Cash Flow (TTM)
-$119M
▼ -43.2% YoY
Net Debt
-$479M
Net Cash Position
Cash & Equiv.
$482M
Continue Research
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with VOR
Held by ETFs
VOR is in 26 US ETFs. The largest of them, with VOR's weight in each:
Vor Biopharma (VOR) in two numbers
Questions about Vor Biopharma
Is Vor Biopharma (VOR) overvalued?
Vor Biopharma trades at 0.07 times earnings. Intrinsiqq's fair value calculator has no opening value for VOR, so weigh those multiples against the company's own history and the peers above. See how to tell if a stock is overvalued.
Does Vor Biopharma (VOR) pay a dividend?
No. Vor Biopharma (VOR) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 26 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 4 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in VOR's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing VOR
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.